This trial is conducted in Europe and the United States of America (USA).
The purpose of this study is to test whether insulin detemir is a safe and at least as
effective alternative to insulin glargine for the control of blood glucose in basal/bolus
therapy in patients with type 2 diabetes.
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Jorvi Hospital, Espoo, Finland
Polyclinique de Minguettes, Venissieux, France
Sykehuset Østfold Sarpsborg HF, Sarpsborg, Norway
Forskningsbyn Ideon, Beta 2, Lund, Sweden
Little Rock, Arkansas 72204, United States
Spring Valley, California 91978, United States
San Francisco, California 94143, United States
Inglewood, California 90301, United States
Santa Ana, California 92705, United States
Orlando, Florida 32804, United States
Melbourne, Florida 32901, United States
New Port Richey, Florida 34652, United States
Vero Beach, Florida 32960, United States
Boca Raton, Florida 33433, United States
Winter Park, Florida 32789, United States
Jacksonville, Florida 32205, United States
Athens, Georgia 30606, United States
Idaho Falls, Idaho 83404, United States
Topeka, Kansas 66606, United States
Omaha, Nebraska 68131, United States
Las Vegas, Nevada 89119, United States
Berlin, New Jersey 08009, United States
Asheville, North Carolina 28801, United States
Hermitage, Pennsylvania 16148, United States
Philadelphia, Pennsylvania 19107, United States
Dallas, Texas 75235, United States
Dallas, Texas 75246, United States
Dallas, Texas 75390-8858, United States
San Antonio, Texas 78229, United States
Norfolk, Virginia 23502, United States
Richmond, Virginia 23249, United States
Tacoma, Washington 98405, United States